{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-23-029920","form_type":"8-K","ticker":"BKYI","cik":"0001019034","company_name":"BIO KEY INTERNATIONAL INC","filed_at":"2023-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:27.895224+00:00","generated_at":"2026-06-08T23:04:30.882168+00:00","sec_items":["1.01","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"BIO-key closes $3.75M public offering; net $3.3M to repay debt and for working capital","bullets":["Gross proceeds $3.75M from sale of 21.43M units at $0.175/unit; each unit comprises one share (or pre-funded warrant) and one 5-year warrant exercisable at $0.175.","Net proceeds approximately $3.3M after deducting placement agent fees and offering expenses.","Company intends net proceeds to repay up to $2.2M of outstanding debt and for general corporate and working capital.","Offering closed October 31, 2023; Maxim Group LLC acted as sole placement agent with a 7% cash fee."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-23-029920","json":"https://secwatch.observer/filing/0001437749-23-029920.json","markdown":"https://secwatch.observer/filing/0001437749-23-029920.md","text":"https://secwatch.observer/filing/0001437749-23-029920.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923029920/0001437749-23-029920-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923029920/bkyi20231101_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-08T23:04:30.882168+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7013cf0aaf0d77bb42d51a37b4b2e20ec61d9059","claim":"BIO KEY INTERNATIONAL INC entered into Purchase Agreement with certain investors (effective 2023-10-30).","evidence_excerpt":"On October 30, 2023, BIO-key International, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with certain investors in connection with a public offering of the Company’s securities (the “ Offering ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923029920/0001437749-23-029920-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain investors"},{"label":"Effective","value":"2023-10-30"}],"fact_type":"material_agreement"},{"claim_id":"f5ce429f864603fb3b245a8c135cccf595a921fd","claim":"BIO KEY INTERNATIONAL INC entered into Placement Agency Agreement with Maxim Group LLC (effective 2023-10-30).","evidence_excerpt":"On October 30, 2023, the Company entered into a placement agency agreement (the “ Placement Agency Agreement ”) with Maxim Group LLC to serve as its exclusive placement agent in connection with the Offering.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1019034/000143774923029920/0001437749-23-029920-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Maxim Group LLC"},{"label":"Effective","value":"2023-10-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}